Sakari Telimaa

No ORCID on file · 8 papers in corpus · active 1987-1991

Study types

  • article 7
  • book-chapter 1

Condition tags

  • mesh:D004715 7
  • endometriosis 7
  • infertility 3
article 1991
Lakartidningen
article 1990
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/0028-2243(90)90055-6
article 1989
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(89)90738-2
article 1989
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.1989.68.s150.7

Progestins, including medroxyprogesterone acetate (MPA), danazol and gestrinone, are used in the medical management of endometriosis. Danazol and gestrinone, by inducing progestin-like effects, closely resemble MPA in their actions on intra…

article 1988
Fertility and Sterility ·doi:10.1016/s0015-0282(16)60364-3
book-chapter 1987
·doi:10.1159/000414861

Studies on cytosol endometrial estrogen and progestin receptor concentrations and 17s-hydroxysteroid dehydrogenase activity have shown that the effects of danazol and medroxyprogesterone acetate (MPA) are similar. Therefore we conducted a p…

article 1987
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.3109/09513598709082692

A prospective, double-blind, placebo-controlled study was designed to evaluate the clinical efficacy and tolerance of danazol and high-dose medroxyprogesterone acetate (MPA) in the treatment of mild-moderate endometriosis. After laparoscopi…

article 1987
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.3109/09513598709082709

To evaluate the clinical value of postoperative hormone therapy in endometriosis, 60 patients with advanced disease were randomized to receive in a double-blind study danazol (200 mg, 3 times daily), medroxyprogesterone acetate (MPA) (100 m…